Publications

(Displaying in Reverse Chronological Order)

  1. Research
  2. Publications
  3. Publications
2161
Mital A, Lad R, Thakur A, Negi VS and Ramachandran U. Synthesis of novel 2-substituted 1,4-naphthoquinones using Heck reaction in 'green' reaction media ARKIVOC 2006, 2006, 99-106.
2162
Mital A, Negi VS and Ramachandran U. Synthesis and antimycobacterial activities of certain trifluoromethyl- aminoquinoline derivatives ARKIVOC 2006, 2006, 220-227.
2163
Modi S, Jain JP, Domb AJ and Kumar N. Copolymers of pharmaceutical grade lactic acid and sebacic acid: Drug release behavior and biocompatibility European Journal of Pharmaceutics and Biopharmaceutics 2006, 64, 277-286.
2164
Mondal K, Roy I and Gupta M. Affinity-based strategies for protein purification Analytical Chemistry 2006, 78, 3499-3504.
2165
Monks TJ, Xie R, Tikoo K, Lau SS. Ros-Induced Histone Modifications and their Role in Cell Survival and Cell Death Drug metabolism reviews 2006, 38, 755-767.
2166
Nayyar A, Malde A, Coutinho E and Jain R. Synthesis, anti-tuberculosis activity, and 3D-QSAR study of ring-substituted-2/4-quinolinecarbaldehyde derivatives Bioorganic & Medicinal Chemistry 2006, 14, 7302-7310.
2167
Nayyar A, Malde A, Jain R and Coutinho E. 3D-QSAR study of ring-substituted quinoline class of anti-tuberculosis agents Bioorganic & Medicinal Chemistry 2006, 14, 847-856.
2168
Panchagnula R, Bedi S and Yasvanth A. Polymorphism of rifampicin in FDCs: Correlation with in vitro dissolution test Clinical Research and Regulatory Affairs 2006, 23, 53-70.
2169
Panchagnula R, Bedi S and Yasvanth A. Rifampicin dissolution: Polymorphism or crystal defects Clinical Research and Regulatory Affairs 2006, 23, 71-83.
2170
Panchagnula R, Bindra P, Pillai O, Kumar N and Dey CS. Stability of insulin under iontophoretic conditions Die Pharmazie 2006, 61, 1014-1018.
2171
Panchagnula R, Dhanikula RS and Dhanikula AB. An ex vivo characterization of Paclitaxel loaded chitosan films after implantation in mice Current Drug Delivery 2006, 3, 287-297.
2172
Panchagnula R, Gupta A, Kandavilli S and Varma MV. High-throughput evaluation of non-swellable controlled release matrix tablets Drug Development and Industrial Pharmacy 2006, 32, 669-675.
2173
Panchagnula R, Kumar Bajpai A, Agrawal S and Ashokraj Y. Dissolution testing of marketed rifampicin containing fixed dose combination formulations using a new discriminative media: a post marketing retrospective study Die Pharmazie 2006, 61, 851-854.
2174
Panchagnula R, Parmar J, Kaur K, Singh I, Bade SR and Ashokraj Y. Statistical evaluation of physiological variability of rifampicin in fixed dose combinations International Journal of Pharmaceutics 2006, 313, 13-5.
2175
Panchagnula R, Parmar J, Kaur KJ, Singh I and Bhade SR. Plasma pooling to expedite bioequivalence estimation of rifampicin in fixed dose combinations Methods and Findings in Experimental and Clinical Pharmacology 2006, 28, 161-167.
2176
Panda J, Tiwari P and Uppal R. Evaluation of the Rationality of some FDCs: Focus on antihypertensive drugs Indian Journal of Pharmaceutical Sciences 2006, 68, 649-653.
2177
Patel DS and Bharatam PV. New leads for selective GSK-3 inhibition: pharmacophore mapping and virtual screening studies Journal of Computer-Aided Molecular Design 2006, 20, 55-66.
2178
Patel DS, Daga P, Bharatam PV, Dongare RK and Gadre SR. Molecular Electrostatic Potential (MESP) studies on the anti-hyperglycemic agents - 2,5-dihydroxyquinones Indian Journal of Chemistry - Section A Inorganic, Physical, Theoretical and Analytical Chemistry 2006, 45A, 13-20.
2179
Pathan AR, Viswanad B, Sonkusare SK and Ramarao P. Chronic administration of pioglitazone attenuates intracerebroventricular streptozotocin induced-memory impairment in rats Life Sciences 2006, 79, 2209-2216.
2180
Pawar RS and Bhutani KK. New dammarane triterpenoidal saponins from bacopa monniera Indian Journal of Chemistry - Section B Organic and Medicinal Chemistry 2006, 45B, 1511-1514.
2181
Prasad B, Bhutani H and Singh S. Study of the interaction between rifapentine and isoniazid under acid conditions Journal of Pharmaceutical and Biomedical Analysis 2006, 41, 1438-1441.
2182
Ratnam DV, Bhardwaj V and Ravi Kumar MNV. Simultaneous analysis of ellagic acid and coenzyme Q(10) by derivative spectroscopy and HPLC Talanta 2006, 70, 387-391.
2183
Ravi Kumar MNV. A special issue on nanotechnology in advanced drug delivery Journal of Nanoscience and Nanotechnology 2006, 6, 10-9.
2184
Rudrawar S, Besra RC and Chakraborti AK. Perchloric acid adsorbed on silica gel (HClO4-SiO2) as an extremely efficient and reusable catalyst for 1,3-dithiolane/dithiane formation Synthesis 2006, 16, 2767-2771.
2185
Saini AK, Patel RJ, Sharma SS and HS AK. Edaravone attenuates hydroxyl radical stress and augmented angiotensin II response in diabetic rats Pharmacological Research 2006, 54, 10-6.
2186
Sarkar M, Khandavilli S and Panchagnula R. Development and validation of RP-HPLC and ultraviolet spectrophotometric methods of analysis for the quantitative estimation of antiretroviral drugs in pharmaceutical dosage forms Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences 2006, 830, 349-354.
2187
Sayyed SG, Kumar A and Sharma SS. Effects of U83836E on nerve functions, hyperalgesia and oxidative stress in experimental diabetic neuropathy Life Sciences 2006, 79, 777-783.
2188
Sharma SS and Sayyed SG. Effects of trolox on nerve dysfunction, thermal hyperalgesia and oxidative stress in experimental diabetic neuropathy Clinical and Experimental Pharmacology and Physiology 2006, 33, 1022-1028.
2189
Singh PP and Kaur S. Serum amyloid P-component in murine tuberculosis: induction kinetics and intramacrophage Mycobacterium tuberculosis growth inhibition in vitro Microbes and Infection 2006, 8, 541-551.
2190
Singh S, Bhutani H and Mariappan TT. Quality Problems of Anti-Tuberculosis Fixed-Dose Combinations (FDCs): A Way Forward Indian Journal of Tuberculosis 2006, 53, 201-205.
2191
Singh S, Bhutani H and Prasad B. Refocus on the Stability and Quality of Anti-TB Formulations International Journal of Tuberculosis and Lung Disease 2006, 10, 1064-1065.
2192
Singh S, Kaur G, Chakraborti AK, Jain RK and Banerjee UC. Study of the experimental conditions for the lipase production by a newly isolated strain of Pseudomonas aeruginosa for the enantioselective hydrolysis of (+/-)-methyl trans-3(4-methoxyphenyl) glycidate Bioprocess and Biosystems Engineering 2006, 28, 341-348.
2193
Singh S, Singh B, Bahuguna R, Wadhwa L and Saxena R. Stress degradation studies on ezetimibe and development of a validated stability-indicating HPLC assay Journal of Pharmaceutical and Biomedical Analysis 2006, 41, 1037-1040.
2194
Singh SK, Dessalew N and Bharatam PV. 3D-QSAR CoMFA study on indenopyrazole derivatives as cyclin dependent kinase 4 (CDK4) and cyclin dependent kinase 2 (CDK2) inhibitors European Journal of Medicinal Chemistry 2006, 41, 1310-1319.
2195
Soni P and Banerjee UC. Enantioselective reduction of acetophenone and its derivatives with a new yeast isolate Candida tropicalis PBR-2 MTCC 5158 Biotechnology Journal 2006, 1, 80-85.
2196
Soni P, Prasad GS and Banerjee UC. Optimization of physicochemical parameters for the enhancement of carbonyl reductase production by Candida viswanathii Bioprocess and Biosystems Engineering 2006, 29, 149-156.
2197
Sukhpreet and Tiwari P. Role of Medicine Information in the Pharmaceutical Industry Indian Journal of Pharmaceutical Sciences 2006, 68, 801-804.
2198
Tamta H, Kalra S and Mukhopadhyay AK. Biochemical characterization of some pyrazolopyrimidine-based inhibitors of xanthine oxidase Biochemistry (Moscow) 2006, 71, S49-S54..
2199
Tiwari P and Sukhpreet. An investigational study of pharmaceutical care issues in individual patients in a hospital setting International Journal of Risk & Safety in Medicine 2006, 18, 99-105.
2200
Vats P and Banerjee UC. Catalytic characterization of phytase (myo-inositolhexakisphosphate phosphohydrolase) from Aspergillus niger van Teighem: Glycosylation pattern, kinetics and molecular properties Enzyme and Microbial Technology 2006, 39, 596-600.
2201
Vats RK. Palladium(II) acetate [Pd(OAc)2]: A versatile catalyst Synlett 2006, 2006, 329-330.
2202
Verma NK and Dey CS. The anti-leishmanial drug miltefosine causes insulin resistance in skeletal muscle cells in vitro Diabetologia 2006, 49, 1656-1660.
2203
Viswanad B, Srinivasan K, Kaul CL, and Ramarao P. Effect of Tempol on Altered Angiotensin II and Acetylcholine-Mediated Vascular Responses in Thoracic Aorta Isolated from Rats with Insulin Resistance Pharmacological Research 2006, 53, 209-215.
2204
Agarwal S, Sharma S, Agrawal V and Roy N. Caloric restriction augments ROS defense in S cerevisiae, by a Sir2p independent mechanism Free Radical Research 2005, 39, 55-62.
2205
Agrawal S and Panchagnula R. Implication of biopharmaceutics and pharmacokinetics of rifampicin in variable bioavailability from solid oral dosage forms Biopharmaceutics and Drug Disposition 2005, 26, 321-334.

Information: Duration to be uploaded/incorporated on archival site after the completion of process is 12 months.

2627|49|45